Calcitonin gene-related peptide potentiates LPS-induced IL-6 release from mouse peritoneal macrophages

J Neuroimmunol. 1998 Apr 15;84(2):207-12. doi: 10.1016/s0165-5728(97)00257-9.

Abstract

The secretion of IL-6 after stimulation of macrophages has been found to play a central role in the regulation of defense mechanism, haematopoiesis, and acute phase reaction. It was reported that cAMP is involved in the regulation of IL-6 production. Since calcitonin gene-related peptide (CGRP) is known to increase cAMP accumulation in mouse macrophages, we examined whether CGRP would induce IL-6 release in macrophages. Macrophages were obtained from the peritoneal exudate of male Balb/c mouse. The cells were plated on culture dishes at a density of 2.5 x 10(5) cells per well and allowed to adhere for 2 h. After incubation for 48 h with two changes of PRMI-1640, the macrophages were cultured with CGRP and LPS 1 microg/ml for 12 h. The IL-6 level in medium was measured by ELISA kits. The results showed that CGRP had no direct effects on IL-6 production, but it potentiated LPS-induced IL-6 production in a concentration-dependent manner. When CGRP was at a concentration of 10(-10) M, the LPS-induced IL-6 production was increased from 5.16 +/- 0.48 to 8.88 +/- 0.48 ng/ml. The effect of CGRP 10(-10) M was reversed by hCGRP(8-37) 10(-8) M, an antagonist of CGRP1 receptor. The LPS-induced IL-6 production from macrophages was also potentiated by forskolin 5 microM, an activator of adenylate cyclase. Furthermore, pretreatment with H-89 1 microM or Rp-cAMPS 100 microM, the inhibitors of cAMP-dependent protein kinase, inhibited the effect of CGRP by 31% and 98%, respectively. These results demonstrate that the LPS-induced IL-6 release is potentiated by CGRP via the activation of cAMP pathway in mouse resident peritoneal macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcitonin Gene-Related Peptide / immunology*
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Drug Synergism
  • Enzyme Inhibitors / pharmacology
  • Interleukin-6 / metabolism*
  • Isoquinolines / pharmacology
  • Lipopolysaccharides / pharmacology*
  • Lymphocyte Activation / drug effects
  • Macrophages, Peritoneal / chemistry
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / enzymology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Miotics / immunology
  • Miotics / pharmacology*
  • Peptide Fragments / immunology*
  • Peptide Fragments / pharmacology
  • Receptors, Calcitonin Gene-Related Peptide / immunology
  • Sulfonamides*
  • Thionucleotides / pharmacology

Substances

  • Enzyme Inhibitors
  • Interleukin-6
  • Isoquinolines
  • Lipopolysaccharides
  • Miotics
  • Peptide Fragments
  • Receptors, Calcitonin Gene-Related Peptide
  • Sulfonamides
  • Thionucleotides
  • calcitonin gene-related peptide (8-37)
  • adenosine-3',5'-cyclic phosphorothioate
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Calcitonin Gene-Related Peptide
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide